KEY PRODUCTS
Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
01 1CURIA FRANCE S.A.S. Bon-Encontre FR
01 1Hexetidine
01 1U.S.A
01 1Valid
Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
Certificate Number : R1-CEP 2005-238 - Rev 03
Status : Valid
Issue Date : 2022-08-25
Type : Chemical
Substance Number : 1221
20
Curia France S.a.s. Bon-encontre Fr, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their significant offerings is Hexetidine, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2005-238 - Rev 03
This Chemical Type CEP, issued on August 25, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1221 associated with this CEP further emphasizes
